Deregulation on branded and generic drugs price and its effect: a study of Chinese pharmaceutical market

被引:0
|
作者
Liu, Lu [1 ]
机构
[1] St Bonaventure Univ, Sch Business, Dept Mkt, St Bonaventure, NY 14778 USA
关键词
Health care quality; Health policy; Statistics; Quality; Quantitative research; Public health regulations; COMPETITION; ENTRY;
D O I
10.1108/IJHG-12-2021-0123
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
PurposeThis research studies the effect of deregulation of price cap in pharmaceutical market. Price regulation (either through price cap or reference price) is common practice in the pharmaceutical market but recently there are increasing voices calling for deregulation claiming that deregulation could help in lowering drug price and increase revenue of pharmaceutical firms. Upon those callings, Chinese government removed the price cap regulation in June 2015. The author uses this natural policy experiment to study this effect.Design/methodology/approachIn this study, the author applied the interrupted time series analysis (ITSA) on the revenue data of nine categories of both generic and branded drugs in China from March 2011 to August 2016 (the time frame includes both before and after of the initialization of the deregulation) and analyzed the effect of deregulation.FindingsThe results showed that, whether the revenue of drugs will increase or decrease after the deregulation of price cap depends on the level of competition and the change of patterns of the branded and generic drugs are different. When HHI (Herfindahl-Hirschman index) is sufficiently low (competition is high), revenue does not change as a result of deregulation, when HHI is moderately low (moderate competition), revenue from generic drugs will decrease significantly and revenue from branded drugs will increase significantly, and when HHI is high (low competition), revenue from generic drugs will increase significantly and revenue from branded drugs will decrease significantly.Originality/valueThis is a unique study with a unique data set. Most previous studies focus on regulation of drug price and analyze how this may affect drug revenue; however, this is a natural policy experiment of de-regulation. Moreover, previously most studies focus on reference pricing regulation and this is price-cap, a different mechanism that is rarely studied. The originality/value is high of this article.
引用
收藏
页码:17 / 30
页数:14
相关论文
共 50 条
  • [21] Chinese Lunar New Year effect, investor sentiment, and market deregulation
    Teng, Chia-Chen
    Yang, J. Jimmy
    [J]. FINANCE RESEARCH LETTERS, 2018, 27 : 175 - 184
  • [22] Study on the Awareness of Clinicians and Postgraduates About Generic Versus Branded Drugs in Andhra Medical College
    Santhilakshmi, C. H.
    Sudha, J.
    Lalitha, K.
    Sureshbabu, N.
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 : S56 - S56
  • [23] Stock Price Limit and Its Predictability in the Chinese Stock Market
    Liang, Haohui
    Hu, Yujia
    [J]. JOURNAL OF FORECASTING, 2024,
  • [24] THE DIFFERENCE BETWEEN THE MAXIMUM RETAIL PRICE AND TENDER PRICE: A COMPARATIVE STUDY ON BRANDNAME AND GENERIC DRUGS
    Liu, B.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A73 - A73
  • [25] Generic Anticancer Drugs of the Jan Aushadhi Scheme in India and Their Branded Counterparts: The First Cost Comparison Study
    George, Thomas
    Baliga, Manjeshwar S.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [26] THE EFFECT OF GENERIC PRICE COMPETITION ON RETAIL AND WHOLESALE MARGINS ON THE HUNGARIAN STATIN MARKET
    Repassy, B.
    Endrei, D.
    Csakvari, T.
    Boncz, I
    [J]. VALUE IN HEALTH, 2018, 21 : S65 - S65
  • [27] The long-term effect of generic price competition on the Hungarian statin market
    Balázs Répásy
    Tibor Gazsó
    Diána Elmer
    Dalma Pónusz-Kovács
    Fanni Luca Kajos
    Tímea Csákvári
    Bettina Kovács
    Imre Boncz
    [J]. BMC Health Services Research, 23
  • [28] The long-term effect of generic price competition on the Hungarian statin market
    Repasy, Balazs
    Gazso, Tibor
    Elmer, Diana
    Ponusz-Kovacs, Dalma
    Kajos, Fanni Luca
    Csakvari, Timea
    Kovacs, Bettina
    Boncz, Imre
    [J]. BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
  • [29] Pharmaceutical Pricing: An Empirical Study of Market Competition in Chinese Hospitals
    Wu, Jing
    Xu, Judy
    Liu, Gordon
    Wu, Jiuhong
    [J]. PHARMACOECONOMICS, 2014, 32 (03) : 293 - 303
  • [30] Pharmaceutical Pricing: An Empirical Study of Market Competition in Chinese Hospitals
    Jing Wu
    Judy Xu
    Gordon Liu
    Jiuhong Wu
    [J]. PharmacoEconomics, 2014, 32 : 293 - 303